Multiple sclerosis tertiary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Tertiary Prevention== | ==Tertiary Prevention== | ||
The [[drugs]] which are used to treat [[MS]] can reduce the progression of the [[disease]] and delay [[disability]] occurrence but cannot stop the [[disease]]. Finally [[Disability|disabilities]] appear so controlling them can be beneficial in increasing [[MS]] [[patients]]’ [[quality of life]].<ref name="pmid16168933">{{cite journal |author=Kesselring J, Beer S |title=Symptomatic therapy and neurorehabilitation in multiple sclerosis |journal=Lancet neurology |volume=4 |issue=10 |pages=643–52 |year=2005 |pmid=16168933|doi=10.1016/S1474-4422(05)70193-9}}</ref> There is strong evidence that [[exercise]] therapy can improve [[muscle]] function and [[mobility]] in multiple sclerosis patients.<ref name="pmid15674920">{{cite journal |vauthors=Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G |title=Exercise therapy for multiple sclerosis |journal=Cochrane Database Syst Rev |volume= |issue=1 |pages=CD003980 |date=January 2005 |pmid=15674920 |doi=10.1002/14651858.CD003980.pub2 |url=}}</ref> | The [[drugs]] which are used to treat [[MS]] can reduce the progression of the [[disease]] and delay [[disability]] occurrence but cannot stop the [[disease]]. Finally [[Disability|disabilities]] appear so controlling them can be beneficial in increasing [[MS]] [[patients]]’ [[quality of life]].<ref name="pmid16168933">{{cite journal |author=Kesselring J, Beer S |title=Symptomatic therapy and neurorehabilitation in multiple sclerosis |journal=Lancet neurology |volume=4 |issue=10 |pages=643–52 |year=2005 |pmid=16168933|doi=10.1016/S1474-4422(05)70193-9}}</ref> There is strong evidence that [[exercise]] therapy can improve [[muscle]] function and [[mobility]] in multiple sclerosis patients.<ref name="pmid15674920">{{cite journal |vauthors=Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G |title=Exercise therapy for multiple sclerosis |journal=Cochrane Database Syst Rev |volume= |issue=1 |pages=CD003980 |date=January 2005 |pmid=15674920 |doi=10.1002/14651858.CD003980.pub2 |url=}}</ref> For controlling [[tremor]] and [[ataxia]], [[Orthotics|orthotic]] devices can be very helpful.<ref>{{cite journal |author=Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M |title=The effect of mechanical damping loads on disabling action tremor |journal=Neurology |volume=43 |issue=7 |pages=1346-50 |year=1993 |pmid=8327136|doi=}}</ref> | ||
[[ | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 18:20, 4 March 2018
|
Multiple sclerosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Multiple sclerosis tertiary prevention On the Web |
|
American Roentgen Ray Society Images of Multiple sclerosis tertiary prevention |
|
Risk calculators and risk factors for Multiple sclerosis tertiary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tertiary Prevention
The drugs which are used to treat MS can reduce the progression of the disease and delay disability occurrence but cannot stop the disease. Finally disabilities appear so controlling them can be beneficial in increasing MS patients’ quality of life.[1] There is strong evidence that exercise therapy can improve muscle function and mobility in multiple sclerosis patients.[2] For controlling tremor and ataxia, orthotic devices can be very helpful.[3]
References
- ↑ Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". Lancet neurology. 4 (10): 643–52. doi:10.1016/S1474-4422(05)70193-9. PMID 16168933.
- ↑ Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G (January 2005). "Exercise therapy for multiple sclerosis". Cochrane Database Syst Rev (1): CD003980. doi:10.1002/14651858.CD003980.pub2. PMID 15674920.
- ↑ Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M (1993). "The effect of mechanical damping loads on disabling action tremor". Neurology. 43 (7): 1346–50. PMID 8327136.